Tazobactam

CAS 89786-04-9 7 current records 3 historicalSmall Molecule

Who holds supplier records for Tazobactam? 7 organisations hold a current record for Tazobactam: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), India (1), Japan (1) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tazobactam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tazobactam

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tazobactam. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Tazobactam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Tazobactam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG ANSHUN PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2026-092 - Rev 00
Tazobactam
Aug 2026—
FRESENIUS KABI IPSUM S.R.L. VilladoseIT
CEP 2026-141 - Rev 00
Tazobactam
Jul 2026Inspected May 2026
Italy

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Tazobactam are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • HOSPIRA HEALTHCARE INDIA PVT LTD
    Inactive DMF 29675 · filed Aug 2015
  • China · Inactive DMF 24963 · filed May 2011
  • JINGDEZHEN FUXIANG PHARMACEUTICAL CO LTD
    Inactive DMF 23674 · filed Mar 2010

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Tazobactam is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL404).

Chemical identity

IUPAC name
(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Canonical SMILES
C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3
InChIKey
LPQZKKCYTLCDGQ-WEDXCCLWSA-N
Synonyms
CL 298,741, CL-298741, NSC-759887, Tazobactam, YTR-830H, Tazobactamum, CHEBI:9421, YTR-830, CXA201, YTR830, RefChem:891206, J01CG02

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tazobactam?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Tazobactam: Shandong Anxin Pharmaceutical Co., Ltd. (China), Shandong Anshun Pharmaceutical Co., Ltd. (China), APITORIA PHARMA PRIVATE LTD (India), JIANGXI SHTEC BIOSCIENCE CO LTD (China), OTSUKA CHEMICAL CO LTD (Japan), ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD (China) and FRESENIUS KABI IPSUM SRL (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tazobactam Drug Master Files are active?

Shandong Anxin Pharmaceutical Co., Ltd. (DMF 33785, 36268), Shandong Anshun Pharmaceutical Co., Ltd. (DMF 33978), APITORIA PHARMA PRIVATE LTD (DMF 19823), JIANGXI SHTEC BIOSCIENCE CO LTD (DMF 37889), OTSUKA CHEMICAL CO LTD (DMF 31398) and ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD (DMF 38374). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tazobactam records mean?

3 organisations have only inactive Type II DMFs for Tazobactam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tazobactam have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Tazobactam on the EDQM register, including SHANDONG ANSHUN PHARMACEUTICAL CO., LTD. Dezhou (CN) and FRESENIUS KABI IPSUM S.R.L. Villadose (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tazobactam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tazobactam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.